2.
足叶乙甙联合奥沙利铂和足叶乙甙联合顺铂的疗效评价(n=69)
Efficacy evaluation of etoposide plus oxaliplatin (EO) and etoposide plus cisplatin (EP) (n=69)
| Efficacy | EO group (n=34) | EP group (n=35) | P |
| CR: completely response; PR: partial response; SD: stable disease; PD: progressive disease; RR: response rate; DCR: disease control rate; PFS:progression free survival; OS: overall survival. | |||
| CR | 3 | 2 | - |
| PR | 16 | 17 | - |
| SD | 9 | 8 | - |
| PD | 6 | 8 | - |
| RR | 55.9% | 54.3% | 0.894 |
| DCR | 82.4% | 77.1% | 0.591 |
| PFS (month) | 5.5 | 4.7 | 0.638 |
| OS (month) | 10.5 | 9.1 | 0.862 |